The expansion of targetable biomarkers for CAR T cell therapy | Journal of Experimental & Clinical Cancer Research | Full Text
Frontiers | Making CAR T Cells a Solid Option for Solid Tumors | Immunology
Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer - European Urology
CAR-T cells clinical trials* against pancreatic cancer | Download Table
The potential of CAR T cell therapy for prostate cancer | Nature Reviews Urology
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?: Molecular Therapy
CAR T-Cell Therapy: Procedure, Prognosis & Side Effects
Gene modification strategies for next-generation CAR T cells against solid cancers | Journal of Hematology & Oncology | Full Text
Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer - European Urology
City of Hope Opens State-of-Art CAR T Cell Phase I Clinical Trial for Prostate Cancer
CAR T cells reach clinical milestone in prostate cancer | Nature Medicine
Cancers | Free Full-Text | Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer
Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment: Molecular Therapy
CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape: Molecular Therapy
CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
Moffitt
Frontiers | CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape | Immunology
Cancers | Free Full-Text | Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment | HTML
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial | Nature Medicine
Promising CAR T-PSMA Clinical Trial in Patients with Metastatic Castration Resistant Prostate Cancer | Moffitt
CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
Current Progress in CAR-T Cell Therapy for Solid Tumors
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial | Nature Medicine
